Full Breakdown
Reynolds American Donation Precedes FDA Policy Shift on Flavored Vapes
5/21/2026, 11:54:20 PM
$5 Million Donation Triggers FDA Policy Shift
On April 30, a Reynolds American subsidiary contributed $5 million to the Trump-backed super-PAC MAGA Inc., raising the PAC’s total to $8 million. Two days later, Reynolds executives and lobbyists met President Donald Trump at his Jupiter, Florida golf club, urging the removal of FDA restrictions on flavored e-cigarettes. Trump subsequently called FDA Commissioner Marty Makary, who did not answer. Within days the FDA announced the removal of several flavor bans and Makary resigned less than a week after the meeting.
Background: FDA Ban on Flavored Vapes and Youth Use
The FDA had prohibited most fruit- and candy-flavored vaping products after evidence linked them to a surge in youth vaping. A CDC youth survey found that the majority of middle- and high-school e-cigarette users prefer such flavors, prompting the ban as a public-health measure.
Principal Actors
- President Donald Trump
- Reynolds American (owner of Camel and Lucky Strike)
- Altria (owner of Marlboro)
- FDA Commissioner Marty Makary (resigned)
- HHS Secretary Robert F. Kennedy Jr.
- CMS Administrator Mehmet Oz
- White House spokesperson Kush Desai
- Super-PAC MAGA Inc.
- Glas Inc. (Los Angeles-based vape manufacturer)
- Centers for Disease Control and Prevention (CDC)
Timeline of Key Events
- April 30 – Reynolds subsidiary donates $5 million to MAGA Inc.
- May 2 – Tobacco executives meet Trump at his golf club, press for policy change.
- May 3-4 – Trump contacts HHS Secretary Kennedy, CMS head Oz, and attempts to reach Makary.
- May 5-6 – FDA announces dropping the ban on fruit-flavored vapes and authorizes mango and blueberry flavors from Glas Inc.; also permits higher nicotine levels in pouches.
- May 7 – Commissioner Marty Makary resigns, citing disagreement over the e-cigarette policy shift.
Financial and Policy Data
- $5 million donation to MAGA Inc.; total PAC contributions $8 million.
- Reynolds gave $10 million to the 2024 super-PAC and $2.5 million-plus donors attended a White House dinner.
- Trump’s inaugural committee received $3 million from vaping interests, including $1.25 million from the Vapor Technology Association and $1 million each from Altria and Breeze Smoke.
- CDC data: most youth e-cigarette users favor fruit or candy flavors.
Official Statements & Responses
White House spokesperson Kush Desai asserted that the donation “had nothing to do with the administration’s sudden shift in policy.” A MAGA Inc. representative said contributions “align with President Trump’s America First agenda.” The administration cited “gold-standard science” and recent evidence that vaping can aid adult smoking cessation as the basis for the policy change. The FDA’s announcement detailed the removal of fruit-flavor bans and the authorization of mango and blueberry products from Glas Inc., as well as increased nicotine limits for pouches.
Criticism & Opposition
Critics labeled the $5 million contribution a legal “bribe” and an example of “open, shameless graft.” Rep. Seth Magaziner (D-RI) condemned the policy reversal, stating, “In the Trump administration, money beats MAHA every time.” Observers noted the timing of the donation and subsequent FDA actions as indicative of industry influence.
Verbatim Quotes
- “the only guiding factor behind the Trump administration’s health policymaking is gold standard science,” — spokesperson, MAGA Inc.
- “recent evidence that has found [vapes] can help adults quit smoking.” — spokesperson, MAGA Inc.
- “money beats MAHA every time.” — Rep. Seth Magaziner (D-RI)
- “is pleased to accept legal contributions from those who agree with President Trump’s America First agenda and his goal to make America great again.” — spokesperson, MAGA Inc.
Conflicting Reports & Gaps
MAGA Inc. officials claim the donation did not influence the FDA decision, while multiple reports link the donation and Trump’s direct pressure to the policy shift. Precise timestamps for the FDA announcement and Makary’s resignation are not disclosed, and Kush Desai’s comment on the donation’s relevance is incomplete in the source material.
What’s Next
The donation and associated policy change are likely to attract scrutiny during the 2024 election cycle, including potential campaign-finance investigations and congressional inquiries into FDA decision-making processes. Further FDA actions on nicotine-delivery products remain pending.
